NIT
UTHR icon

NumerixS Investment Technologies’s United Therapeutics UTHR Stock Holding History

NumerixS Investment Technologies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-300
Closed -$36K – 812
2020
Q2 		$36K Buy
+300
New +$33.8K 0.01% 865
2020
Q1 		– Sell
-2,000
Closed -$176K – 1293
2019
Q4 		$176K Sell
2,000
-3,200
-62% -$282K 0.03% 526
2019
Q3 		$415K Buy
+5,200
New +$419K 0.11% 196
2019
Q2 		– Sell
-6,800
Closed -$798K – 1358
2019
Q1 		$798K Buy
+6,800
New +$792K 0.11% 229
2018
Q4 		– Sell
-2,600
Closed -$329K – 1387
2018
Q3 		$329K Sell
2,600
-800
-24% -$99K 0.06% 416
2018
Q2 		$379K Buy
+3,400
New +$374K 0.09% 329
2018
Q1 		– Sell
-2,900
Closed -$429K – 1295
2017
Q4 		$429K Buy
2,900
+500
+21% +$63.6K 0.1% 247
2017
Q3 		$281K Buy
2,400
+1,900
+380% +$243K 0.06% 402
2017
Q2 		$65K Sell
500
-1,900
-79% -$237K 0.01% 920
2017
Q1 		$325K Sell
2,400
-1,000
-29% -$151K 0.04% 558
2016
Q4 		$488K Sell
3,400
-100
-3% -$12.8K 0.06% 381
2016
Q3 		$413K Sell
3,500
-4,800
-58% -$577K 0.05% 433
2016
Q2 		$879K Sell
8,300
-9,100
-52% -$1.02M 0.12% 237
2016
Q1 		$1.94M Buy
17,400
+300
+2% +$38K 0.22% 99
2015
Q4 		$2.68M Buy
17,100
+6,200
+57% +$903K 0.33% 53
2015
Q3 		$1.43M Buy
+10,900
New +$1.75M 0.16% 143
2015
Q2 		– Sell
-6,300
Closed -$1.09M – 756
2015
Q1 		$1.09M Buy
+6,300
New +$960K 0.2% 140

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

NumerixS Investment Technologies's UTHR Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of United Therapeutics (UTHR) in Q3 2020, closing a stake of 300 shares — an estimated $36K sold.

NumerixS Investment Technologies first reported a position in UTHR in Q1 2015 and held it in 17 quarters. The position peaked at $2.68M in Q4 2015. 333 funds tracked by Wall St. Rank hold UTHR as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining United Therapeutics position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 300 United Therapeutics shares in Q3 2020, an estimated $36K.
  • NumerixS Investment Technologies first reported a position in United Therapeutics in Q1 2015 and held it in 17 quarters.
  • NumerixS Investment Technologies's United Therapeutics position peaked at $2.68M in Q4 2015.
  • 333 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.